EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 4 (Avril 2003) Med Sci (Paris), 19 4 (2003) 473-476 References
Free Access
Issue
Med Sci (Paris)
Volume 19, Number 4, Avril 2003
Page(s) 473 - 476
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2003194473
Published online 15 April 2003
  1. Vague J. La différenciation sexuelle, facteur déterminant des formes de l’obésité. Presse Med 1947; 30: 339–40. [Google Scholar]
  2. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrinol Rev 1996; 17: 245–61. [Google Scholar]
  3. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11β- hydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001; 15: 61–78. [Google Scholar]
  4. Walker BR. Steroid metabolism in metabolic syndrome X. Best Pract Res Clin Endocrinol Metab 2001; 15: 111–22. [Google Scholar]
  5. Rask E, Olsson T, Soderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418–21. [Google Scholar]
  6. Björntorp P, Rosmond R. The metabolic syndrome: a neuroendocrine disorder ? Br J Nutr 2000; 83: S49–57. [Google Scholar]
  7. Jessop DS, Dallman MF, Fleming D, Lightman SL. Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 2001; 86: 4109–14. [Google Scholar]
  8. Rask E, Walker BR, Söderberg S, et al. Tissuespecific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330–6. [Google Scholar]
  9. Livingstone DEW, Jones GC, Smith K, et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000; 141: 560–3. [Google Scholar]
  10. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166–70. [Google Scholar]
  11. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of the cortisolcortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol 1999; 50: 63–8. [Google Scholar]
  12. Bujalska IW, Kumar S, Stewart PM. Does central obesity reflect Cushing’s disease of the omentum ? Lancet 1997; 349: 1210–3. [Google Scholar]
  13. Bujalska IJ, Kumar S, Hewinson M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β- hydroxysteroid dehydrogenase. Endocrinology 1999; 140: 3188–96. [Google Scholar]
  14. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11β- hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002; 87: 2701–5. [Google Scholar]
  15. Bujalska IJ, Walker EA, Hewinson M, Stewart PM. A switch in dehydrogenase to reductase activity of 11β- hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 2002; 87: 1205–10. [Google Scholar]
  16. Bastelica D, Morange P, Berthet B, et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002; 22: 173–8. [Google Scholar]
  17. Seckl JR, Walker BR. 11β- hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001; 142: 1371–6. [Google Scholar]
  18. Weaver JU, Thaventhiran L, Noonan N, et al. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol (Oxf) 1994; 41: 639–48. [Google Scholar]
  19. Berger J, Tanen M, Elbrecht A, et al. Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β- hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 2001; 276: 12629–35. [Google Scholar]
  20. Kelly IE, Han TS, Walsh K, Lean MEJ. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 1999; 22: 288–93. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.